Stephen A. Moglia serves as Executive at Orexigen Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Stephen A. Moglia has executed 2 insider transactions totaling $2.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 15, 2018 involved selling 1,694 shares valued at $407.
Stephen A. Moglia currently holds 0 shares of Orexigen Therapeutics, Inc. (OREX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stephen A. Moglia has been a net seller of OREX stock. They have purchased $0 and sold $2.0K worth of shares.
Stephen A. Moglia's most recent insider trade was on Mar 15, 2018, when they sold 1,694 shares at $0.24 per share.
Get notified when new Form 4 filings are submitted
| $1.96 |
| Discretionary |